Adherence to tuberculosis care in Canadian Aboriginal populations Part 2: A comprehensive approach to fostering adherent behaviour

International Journal of Circumpolar Health

Volumn 70, Issue 2, 2011, Pages 128-140

  Orr, Pamela ^a  

^a UNIVERSITY OF MANITOBA   (Canada)

Author keywords

Aboriginal; Adherence; Compliance; Indigenous; Public health; Self efficacy; Tuberculosis

Indexed keywords

EID: 79955749445     PISSN: 12399744     EISSN: None     Source Type: Journal    
DOI: 10.3402/ijch.v70i2.17810     Document Type: Review

References (71)

1. Public Health Agency of Canada. Tuberculosis in Canada 2008-Pre-Release. Ottawa: Public Health Agency of Canada; 2009 [cited 2010 June 1]. Available from: http://www.phac-aspc.gc.ca/tbpc-latb/pubs/tbcan08pre/indexeng.
2. Orr P. Adherence to tuberculosis care in Canadian Aboriginal populations. Part 1: Definition, measurement, responsibility, barriers. Int J Circumpolar Health 2011;70(2):113-127.
3. Garner P, Smith H, Munro S, Volmink J. Promoting adherence to tuberculosis treatment. Bull World Health Organ 2007;85(5):404-406.
4. Volmink J, Matchaba P, Garner P. Directly observed therapy and treatment adherence. Lancet 2000;355(9212):1345-1350.
5. Mangura BT, Galanowsky KE. Case management: the key to a successful tuberculosis control program. In: Reichman LB, Hershfield EH, editors. Tuberculosis: a comprehensive international approach. New York: Marcel Dekker; 2000. p. 597-608.
6. Mangura B, Napolitano E, Passannante M, Sarrel M, Mc-Donald R, Galanowsky K et al. Directly observed therapy (DOT) is not the entire answer: an operational cohort analysis. Int J Tuberc Lung Dis 2002;6(8):654-661.
7. Reichman LB, Mangura BT. And the beat goes on. Am J Resp Crit Care Med 2005;172:140.
8. Hoeppner VH. Tuberculosis in Saskatchewan treaty Indians. Prairie Medical Journal 1995;65(1):18-20.
9. Heal G, Elwood RK, FitzGerald JM. Acceptance and safety of directly observed versus self-administered isoniazid preventive therapy in Aboriginal peoples in British Columbia. Int J Tuberc Lung Dis 1998;2(12):979-983.
10. McNab BD, Marciniuk DD, Alvi RA, Tan L, Hoeppner VH. Twice weekly isoniazid and rifampin treatment of latent tuberculosis infection in Canadian plains Aborigines. Am J Respir Crit Care Med 2000;162(3 Pt 1):989-993.
11. Volmink J, Garner P. Directly observed therapy for treating tuberculosis. Cochrane Database of Systematic Reviews 2007;(4):CD003343. DOI:10.1002/14651858. CD003343.pub3.
12. Bayer R, Wilkinson D. Directly observed therapy for tuberculosis: history of an idea. Lancet 1995;345(8964):1545-1548.
13. Awofeso N. Anti-tuberculosis medication side-effects constitute major factor for poor adherence to tuberculosis treatment. Bull World Health Organ 2008;86(3):161.
14. Munro SA, Lewin SA, Smith HJ, Engel ME, Fretheim A, Volmink J. Patient adherence to tuberculosis treatment: a systematic review of qualitative research. PLoS Med 2007;4(7):e238.
15. McRae M, Taylor SJ, Swain L, Sheldrake C. Evaluation of a pharmacist-led, medicines education program for Aboriginal Health Workers. Rural Remote Health 2008;8(4):946.
16. Stoneman J, Taylor SJ. Pharmacists' views on Indigenous health: is there more that can be done? Rural Remote Health 2007;7(3):743.
17. Clark P, Karagoz T, Apikoglu-Rabus S, Izzettin FV. Effect of pharmacist-led education on adherence to tuberculosis treatment. Am J Health Syst Pharm 2007;64(5):497-506.
18. Browne AJ. The meaning of respect: a First Nations perspective. Can J Nurs Res 1995;27(4):95-109.
19. Towle A, Godolphin W, Alexander T. Doctor-patient communications in the Aboriginal community: towards the development of educational programs. Patient Educ Couns 2006;62(3):340-346.
20. Teutsch C. Patient-doctor communication. Med Clin North Am 2003;87(5):1115-1145.
21. O'Brien MK, Petrie K, Raeburn J. Adherence to medication regimens: updating a complex medical issue. Med Care Rev 1992:49(4):435-453.
22. Sabaté E, editor. Adherence to long-term therapies: evidence for action. Geneva: World Health Organization; 2003. 209 p.
23. Jenkins D. Tuberculosis: The Native Indian viewpoint on its prevention, diagnosis and treatment. Prev Med 1977;6(4):545-555.
24. Tempest P, Pesanti E Jr. A community-wide tuberculosis case finding program on the Navajo reservation. Am Rev Respir Dis 1974;110(6):760-764.
25. Walt G, Gilson L et al., editors. Community health workers in national programmes: Just another pair of hands? Philadelphia: Open University Press; 1990. 180 p.
26. Peiris D, Brown A, Cass A. Addressing inequities in access to quality health care for Indigenous people. CMAJ 2008;179(10):985-986.
27. CBC News. Family angered by man's ER death. CBC News; 25 September 2008 [cited 2010 June 1]. Available from: http://www.cbc.ca/news/health/story/2008/09/25/mb-sinclair-family.html.
28. Wobeser W, To T, Hoeppner VH. The outcome of chemoprophylaxis on tuberculosis prevention in the Canadian Plains Indian. Clin Invest Med 1989;12(3):149-153.
29. Bock NN, Sales RM, Rogers T, DeVoe B. A spoonful of sugar...: improving adherence to tuberculosis treatment using financial incentives. Int J Tuberc Lung Dis 2001;5(1):96-98.
30. Tulsky JP, Hahn JA, Long HL, Chambers DB, Robertson MJ, Chesney MA et al. Can the poor adhere? Incentives for adherence to TB prevention in homeless adults. Int J Tuberc Lung Dis 2004;8(1):83-91.
31. American Thoracic Society and Centers for Disease Control. Targeted tuberculin testing and treatment of latent tuberculosis infection. MMWR Recomm Rep 2000;49(RR-6):1-54.
32. Papps E, Ramedan I. Cultural safety in nursing: the New Zealand experience. Int J Qual Health Care 1996;9(5):491-497.
33. th ed. Ottawa: Public Health Agency of Canada; 2007. p. 298-307.
34. Nguyen D, Proulx J-F, Westley J, Thibert L, Dery S, Behr MA. Tuberculosis in the Inuit community of Quebec, Canada. Am J Respir Crit Care Med 2003;168(11):1353-1357.
35. Fitzgerald JM, Wang L, Elwood RK. Tuberculosis: 13. Control of the disease among Aboriginal people in Canada. CMAJ 2000;162(3):351-355.
36. Valeza FS, McDougall AC. Blister calendar packs for treatment of tuberculosis. Lancet 1990;335(8687):473.
37. Van Dulman S, Sluijs E, van Dijk L, de Ridder D, Heerdink R, Bensing J. Patient adherence to medical treatment: a review of reviews. BMC Health Serv Res 2007;7:55.
38. th ed. Ottawa: Public Health Agency of Canada; 2007. p. 114-145.
39. Squire SB. Directly observed therapy and other aspects of management of tuberculosis care. In: Davies PDO, Barnes PF, Gordon SB, editors. Clinical tuberculosis 4th ed. Hodder Arnold publication. Oxford University Press; 2008. p. 287-297.
40. Mehl-Madrona L. Narrative Medicine. Rochester: Bear and Company; 2007. 336 p.
41. Morrisseau C. Into the daylight. A wholistic approach to healing. Toronto: University of Toronto Press; 1998. 112 p.
42. Irniq P. Healthy community. Arctic 2008;61(Suppl 1):1-3.
43. Waldrom JB. Revenge of the Windigo. The construction of the mind and mental health of North American Aboriginal peoples. Toronto: University of Toronto Press; 2004. 414 p.
44. Gibson N, Cave A, Doering D, Ortiz L, Harms P. Sociocultural factors influencing prevention and treatment of tuberculosis in immigrant and Aboriginal communities in Canada. Soc Sci Med 2005;61(5):931-942.
45. Gibson N, Cave A, Doering D. Targeting TB. Sociocultural factors affecting tuberculosis treatment and prevention in Aboriginal and immigrant populations in Alberta. Edmonton: University of Alberta; 2002 [cited 2010 Feb 20]. Available from: http://www.uofaweb.ualberta.ca/acadre//pdfs/targeting_tb.pdf.
46. San Sebastian M, Bothamley GH. Tuberculosis preventive therapy: Perspective from a multi-ethnic community. Respir Med 2000;94(7):648-653.
47. Rubel AJ, Garro LC. Social and cultural factors in the successful control of tuberculosis. Public Health Rep 1992;107(6):626-636.
48. Charon R. Narrative medicine. Honoring the stories of illness. New York: Oxford University Press; 2006. 266 p.
49. Dick J, Lombard C. Shared vision-a health education project designed to enhance adherence to anti-tuberculosis treatment. Int J Tuberc Lung Dis 1997;1(2):181-186.
50. White MC, Tulsky JP, Goldenson J, Portillo CJ, Kawamura M, Menendez E. Randomized controlled trial of interventions to improve follow-up for latent tuberculosis infection after release from jail. Arch Intern Med 2002;162(9):1044-1050.
51. McConnel F. Compliance, culture and the health of Indigenous people. Rural Remote Health 2003;3(1)190.
52. Bryce S. Lessons from east Arnhem land-improving adherence to chronic disease treatments. Aust Fam Physician 2002;31(7):617-621.
53. Hansel NN, Wu AW, Chang B, Diette GB. Quality of life in tuberculosis: patient and provider perspectives. Qual Life Res 2004;13(3):639-652.
54. Zinken KM, Cradock S, Skinner TC. Analysis System for Self-Efficacy Training (ASSET). Assessing treatment fidelity of self-management interventions. Patient Educ Couns 2008;72(2):186-193.
55. Oeltmann JE, Kammerer JS, Pevzner ES, Moonan PK. Tuberculosis and Substance Abuse in the United States, 1997-2006. Arch Intern Med 2009;169(2):189-197.
56. Hunter LM, Logan J, Goulet JG, Barton S. Aboriginal healing: regaining balance and culture. J Transcult Nurs 2006;17(1):13-22.
57. Wertele SK, Galanos AN, Roberts MC. Increasing return compliance in a tuberculosis detection drive. J Behav Med 1980;3(3):311-318.
58. DiMatteo MR. Social support. Health Psychol 2004;23:207-218.
59. Edwards BB. The breakfast club. Fla Nurse 1988;36(10):9.
60. Chief Joe Dantouze, Northlands Denesuline First Nations. Witness Testimony, House of Commons Standing Committee on Health, Evidence, April 20, 2010. HESA (40-3), Number 010, Third Session, 40th Parliament of Canada [cited 2010 Sept 24]. Available from: http://www2.parl.gc.ca/HousePublications/Publication.aspx?Language=E&Mode=1&Parl=40&Ses=3&DocId=4443113&File=0.
61. Chief Angus Toulouse, Regional Chief, Assembly of First Nations. Witness Testimony. House of Commons Standing Committee on Health, Evidence, April 20, 2010. HESA (40-3), Number 010, Third Session, 40th Parliament of Canada [cited 2010 Sept 24]. Available from: http://www2.parl.gc.ca/HousePublications/Publication.aspx?Language=E&Mode=1&Parl=40&Ses=3&DocId=4443113&File=0.
62. Assembly of First Nations. Tuberculosis: Global Indigenous STOP TB. First Nations' Public Health; 2009 [cited 2010 Sept 24]. Available from: http://fnpublichealth.ca/tb/global-indigenous-stop-tb/.
63. The University of Western Australia, School of Population Health. Review Support Document; 2007 [cited 2010 Sept 24]. Available from: http://www.uwa.edu.au/__data/assets/pdf_file/0018/431370/The_School_of_Population_Health.pdf.
64. Farmer P. Infections and inequalities. The modern plagues. Berkeley: University of California Press; 1999. 375 p.
65. Warren P. Physician advocacy is essential for Canada's First Nations. CMAJ 2008;179(7):728.
66. Feldberg GD. Disease and class: Tuberculosis and the shaping of modern North American society. New Brunswick, NJ: Rutgers University Press; 1995. 274 p.
67. Bryce P. The story of a national crime: being an appeal for justice to the Indians of Canada. Ottawa: James Hope and Sons Ltd.; 1922 [cited 2010 March 20]. p 3-18. Available from:http://www.archive.org/details/storyofnationalc00brycuoft.
68. Legal Forum: cross-jurisdictional issues in tuberculosis control. October 3, 2007. United States-México Border Health Commission; 2007 [cited 2010 March 1]. Available from: http://www.borderhealth.org/extranet/files/file_1150.pdf.
69. Furnish DB. The Navajo nation: a three-ingredient mix. Electronic Journal of Comparative Law 2008;12(1) [cited 2010 March 1]. Available from: http://www.ejcl.org.
70. th ed. Ottawa: Public Health Agency of Canada; 2007. p. 146-181.
71. Guidelines for tuberculosis control in New Zealand 2001. Wellington: Ministry of Health; 2001 [cited 2010 Jan7]. Available from: http://www.nzgg.org.nz/guidelines/0033/TBControlGuidelines03.pdf.